BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210712T120000
DTEND;TZID=America/Toronto:20210712T130000
DTSTAMP:20210624T204632Z
CREATED:20210624T204632Z
LAST-MODIFIED:20210624T204632Z
UID:15116-1626091200-1626094800@scienceinboston.com
SUMMARY:Developing New Cancer Therapies: Patients as Partners
DESCRIPTION:Linnea Olson is a patient advocate\, activist\, blogger and artist. She has been a participant in six phase I clinical trials for ALK-mutant non-small cell lung cancer (NSCLC) – three of which led to FDA approval of new targeted therapies. Her experiences and wisdom have made her a trusted source of insight for countless patients\, researchers\, clinicians\, biotech and pharmaceutical companies\, and learners at Harvard Medical School. \nIn this special event\, we will premiere a brief video outlining Linnea Olson’s remarkable journey. This will be followed by a panel discussion in which Linnea will be joined by two senior drug development leaders whose therapies have played such an important part in Linnea’s story. Join us for a wide-ranging discussion on patient-centric drug discovery and development\, exciting advances in cancer treatments\, and living with cancer.
URL:https://scienceinboston.com/event/developing-new-cancer-therapies-patients-as-partners-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210712T120000
DTEND;TZID=America/Toronto:20210712T130000
DTSTAMP:20210624T204632Z
CREATED:20210624T204632Z
LAST-MODIFIED:20210624T204632Z
UID:27726-1626091200-1626094800@scienceinboston.com
SUMMARY:Developing New Cancer Therapies: Patients as Partners
DESCRIPTION:Linnea Olson is a patient advocate\, activist\, blogger and artist. She has been a participant in six phase I clinical trials for ALK-mutant non-small cell lung cancer (NSCLC) – three of which led to FDA approval of new targeted therapies. Her experiences and wisdom have made her a trusted source of insight for countless patients\, researchers\, clinicians\, biotech and pharmaceutical companies\, and learners at Harvard Medical School. \nIn this special event\, we will premiere a brief video outlining Linnea Olson’s remarkable journey. This will be followed by a panel discussion in which Linnea will be joined by two senior drug development leaders whose therapies have played such an important part in Linnea’s story. Join us for a wide-ranging discussion on patient-centric drug discovery and development\, exciting advances in cancer treatments\, and living with cancer.
URL:https://scienceinboston.com/event/developing-new-cancer-therapies-patients-as-partners-2-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR